Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 805 of 1,261
  1. US 8779094

    Low viscosity highly concentrated suspensions

    The Board of Regents of the University of Texas System · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  2. US 8778897

    Method of treatment using α-1-adrenergic agonist compounds

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  3. US 8778898

    Oligomer conjugates of heteropentacyclic nucleosides

    Nektar Therapeutics · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  4. US 8778913

    Antimicrobial compositions for treating microbial infections

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  5. US 8772482

    4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  6. US 8772483

    Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  7. US 8772495

    5-lipoxygenase-activating protein inhibitor

    Panmira Pharmaceuticals, LLC · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  8. US 8772453

    Compositions for linking zinc finger modules

    Sangamo Biosciences, Inc. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  9. US 8772479

    Oligomer-containing substituted aromatic triazine compounds

    Nektar Therapeutics · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  10. US 8772291

    Multicyclic compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  11. US 8772288

    Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors

    Almirall, S.A. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  12. US 8771648

    (Trimethoxyphenylamino) pyrimidinyl formulations

    Rigel Pharmaceuticals, Inc. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  13. US 8771731

    Antimicrobial nanoemulsion compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  14. US 8772013

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  15. US 8772238

    Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  16. US 8772306

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals, Inc. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  17. US 8772331

    Small molecule antagonists of bacterial quorum-sensing receptors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  18. US 8771965

    Methods and compositions involving nucleotide repeat disorders

    The Board of Regents of the University of Texas System · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  19. US 8771662

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  20. US 8772258

    Single walled carbon nanotube/sirna complexes and methods related thereto

    Ensysce Biosciences Inc. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  21. US 8772256

    Codon modified immunogenic compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  22. US 8772246

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  23. US 8771985

    Genome editing of a Rosa locus using zinc-finger nucleases

    Sangamo Biosciences, Inc. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  24. US 8771735

    Immediate release dosage forms of sodium oxybate

    Jazz Pharmaceuticals, Inc. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.